Stock ALBIO BIOSYNEX
Add to a list
To use this feature you must be a member
Log inSign up

All News Biosynex

Equities

ALBIO

FR0011005933

Real-time Euronext Paris
Other stock markets
 16:35:19 03/05/2024 BST 		5-day change 1st Jan Change
4.2 EUR -0.47% Intraday chart for Biosynex +2.69% -49.70%
04-30 Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2023 CI
04-29 Biosynex: agreement for ProciseDx in North America CF

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Biosynex: agreement for ProciseDx in North America
CF
Biosynex: merger with Theradiag completed
CF
Biosynex SA Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Biosynex: acquisition of Qualigen in the United States
CF
Biosynex Unit to Acquire US-based Biotech Qualigen
MT
Biosynex SA acquired 57.33% interest in ProciseDx Inc. from Nestlé HealthCare Nutrition, Inc., other shareholders, employees, former employees and investors.
CI
Biosynex SA signed an agreement to acquire 57.33% interest in ProciseDx Inc. from Nestlé HealthCare Nutrition, Inc., other shareholders, employees, former employees and investors.
CI
Biosynex: acquires Innoxa's eye care business
CF
Biosynex SA acquired Eye Care activity from LABORATOIRES INNOXA.
CI
Biosynex Completes Acquisition of Chembio Diagnostics, Inc.
AQ
Biosynex SA completed the acquisition of Chembio Diagnostics, Inc. from Perceptive Advisors LLC and others.
CI
Global markets live: EssilorLuxottica, AT&T, Tesla, Credit Suisse, Sony...
Our Logo
Biosynex: share price falls as results deteriorate
CF
Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Chembio Diagnostics Tender Offer Expiration Extended by Biosynex
MT
Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.
AQ
Biosynex: takeover bid extended for Chembio Diagnostics
CF
Biosynex Unit Extends Expiration Time of Tender Offer for Chembio Diagnostics Shares; Stock Rises
MT
Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALBIO Stock
  4. News Biosynex